[Form 4] Amrize Ltd Insider Trading Activity

Rhea-AI Filing Summary

Amrize Ltd director Robert S. Rivkin reported the acquisition of 2,958 ordinary shares in the form of a restricted stock unit (RSU) award under the Amrize Ltd 2025 Omnibus Incentive Plan. The award is recorded at a $0 price and is held directly following the transaction.

The RSUs vest on the earlier of the one-year anniversary of the grant and the issuer's next regular annual meeting of shareholders. The Form 4 shows the reported transaction date as 08/11/2025 and indicates the filing was made by one reporting person with an attorney-in-fact noted on the form.

Insights

Financial Analyst

TL;DR: Small director RSU grant of 2,958 shares; recorded at $0 and subject to one-year/meeting vesting.

The filing documents a time-based RSU award to a director that increases direct beneficial ownership by 2,958 shares. The award price is reported as $0, consistent with a grant rather than an open-market purchase. Given the modest share count disclosed and the defined vesting condition, this transaction appears routine and unlikely to be materially dilutive at company scale based solely on the disclosed amount.

Corporate Governance Expert

TL;DR: Governance note: director received time-based RSUs with standard vesting tied to anniversary or next annual meeting.

The Form 4 clearly identifies the award as a restricted stock unit under the companys 2025 Omnibus Incentive Plan, with vesting on the earlier of one year or the next annual meeting of shareholders. The report names the recipient as a Director and records direct ownership following the grant. This disclosure aligns with standard insider-reporting practices for executive and director equity awards.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Rivkin Robert S.

(Last) (First) (Middle)

GRAFENAUWEG 8

(Street)

ZUG V8 6300

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Amrize Ltd [ AMRZ ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
08/11/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Ordinary Shares	08/11/2025		A		2,958(1)	A	$0	2,958	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Restricted stock unit award to the reporting person pursuant to the Amrize Ltd 2025 Omnibus Incentive Plan. The award vests on the earlier of the one-year anniversary of the grant date and the date of the issuer's next regular annual meeting of shareholders.

	Hans Weinburger, Attorney-in-Fact	08/13/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transaction did AMRZ director Robert S. Rivkin report?

The report discloses an acquisition of 2,958 ordinary shares as a restricted stock unit award under the Amrize Ltd 2025 Omnibus Incentive Plan.

What price was reported for the shares in the Form 4 for AMRZ?

The award is reported at a $0 price, indicating a granted restricted stock unit rather than a market purchase.

What are the RSU vesting terms reported in AMRZ's Form 4?

The RSUs vest on the earlier of the one-year anniversary of the grant and the issuers next regular annual meeting of shareholders.

How many shares does Rivkin beneficially own after the reported transaction?

The Form 4 shows 2,958 shares beneficially owned following the reported transaction, held directly.

Was the Form 4 filed jointly or by one reporting person for AMRZ?

The filing indicates the form was filed by one reporting person and includes an attorney-in-fact signature line.

Did the filing report any derivative securities for AMRZ?

No derivative securities are reported in Table II; only the non-derivative RSU award appears in Table I.